Related references
Note: Only part of the references are listed.Suppressive effects of sunitinib on a TLR activation-induced cytokine storm
Sheng Zhao et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2019)
TLR4: An Important Molecule Participating in Either Anti-Human Papillomavirus Immune Responses or Development of Its Related Cancers
Reza Bahramabadi et al.
VIRAL IMMUNOLOGY (2019)
TLR4 antagonist FP7 inhibits LPS-induced cytokine production and glycolytic reprogramming in dendritic cells, and protects mice from lethal influenza infection
Laure Perrin-Cocon et al.
SCIENTIFIC REPORTS (2017)
The link between TLR7 signaling and hepatitis B virus infection
Zahra Sepehri et al.
LIFE SCIENCES (2016)
Novel drugs targeting Toll-like receptors for antiviral therapy
Mira C. Patel et al.
FUTURE VIROLOGY (2014)
TLR3 plays significant roles against hepatitis B virus
Masoud Karimi-Googheri et al.
MOLECULAR BIOLOGY REPORTS (2014)
Toll-Like Receptor 4 and Hepatitis B Infection: Molecular Mechanisms and Pathogenesis
Mohammad Zare-Bidaki et al.
VIRAL IMMUNOLOGY (2014)
A human microsatellite DNA-mimicking oligodeoxynucleotide with CCT repeats negatively regulates TLR7/9-mediated innate immune responses via selected TLR pathways
Ran Sun et al.
CLINICAL IMMUNOLOGY (2010)
Toll-like receptor signaling inhibits hepatitis B virus replication in vivo
M Isogawa et al.
JOURNAL OF VIROLOGY (2005)
Role of Toll-like receptors in costimulating cytotoxic T cell responses
K Schwarz et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2003)
Share Paper
